CureBay
PrivateLast Round
Series B
May 20, 2025
Est. Valuation
$75M
Total Funding Raised
$34.7M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
CureBay is a health-tech company that operates a hybrid network of e-clinics and pharmacies to provide accessible and affordable primary healthcare services to rural communities in India.
Sector
Healthcare & Life Sciences
Verticals
Telemedicine, Pharma Supply Chain, Patient Engagement, E-commerce
Business Model
B2C
Customer Profile
Usage-Based SaaS, Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CureBay Comparables
Compare CureBay with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Gramin Health Care | 83% | |
| Karma Primary Healthcare | 83% | |
| Jiyyo Innovations Private Limited | 81% |
CureBay Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | May 20, 2025 | ||||
| Series A Extension | Jan 5, 2024 | ||||
| Debt | Aug 26, 2023 | ||||
| Series A | Nov 9, 2022 | ||||
| Angel | Sep 16, 2022 |
Key People
Founding team and executive leadership
CureBay Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bertelsmann Investments | Series B |
| InCred Wealth | Angel, Series A Extension |
| Stride Ventures | Debt |
| Elevar Equity | Series B, Series A Extension, Series A |
| British International Investment | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 16, 2026
Monthly visitors grew 39% MoM, reaching 45.9K.
- Apr 16, 2026
Grew 17% QoQ, from 283 to 331 employees.
CureBay Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about CureBay's valuation, stock price, and market status.
Is CureBay a public or private company?
CureBay is a private company.
What is the current stock price of CureBay?
CureBay is a private company with no public stock price. No recent secondary market data is available.
How much is CureBay worth (valuation)?
CureBay's valuation is estimated at $75.0M based on funding round data.
Can I buy CureBay stock?
CureBay shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was CureBay's last funding round?
CureBay's most recent funding round was Series B on May 20, 2025.
Who are the main investors in CureBay?
Key investors in CureBay include Bertelsmann Investments, Elevar Equity.
Will CureBay IPO soon?
No public IPO plans have been announced for CureBay.
How can I track CureBay secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor CureBay's secondary market activity and sign up for updates.